SARS-CoV-2 antibody seroprevalence in a London HIV clinic cohort

The COVID-19 pandemic started in London during the latter part of January 2020 and reached its peak in April 2020. Antibodies to the SARS-CoV-2 develop 2–3 weeks after exposure and decreases following recovery from illness.1 In the UK, patients accessing the National Health Service were able to request SARS-CoV-2 antibody testing since May 2020. Patients attending our HIV clinic were able to opt-in for SARS-CoV-2 antibody testing during their routine monitoring visit for blood tests. Laboratory tests were used to detect SARS-CoV-2 nucleic acid antibodies in serum samples. A retrospective study was conducted to know the seropositivity rate among the tested cohort of our large central London HIV clinic. We collected data of people living with HIV who opted-in for SARS-CoV-2 antibody test from 1 May 2020 to 31 December 2020. Data on demographics, body mass index (BMI), comorbidities, concomitant medications, Antiretroviral therapy (ART), CD4 count and HIV...
Source: Sexually Transmitted Infections - Category: Sexual Medicine Authors: Tags: COVID-19 Research letter Source Type: research